Spurred in part by nearly $2 million in state incentives, GlaxoSmithKline is going to expand its manufacturing facility in Zebulon.
The growth plans call for an investment of $92 million and the creation of some 200 jobs over the next four years, according to Gov. Mike Easley.
The state is providing GSK with a $1.39 million job development investment grant as well as a $500,000 grant from the One North Carolina Fund.
“The competition for these types of jobs is fierce,” Easley said in a statement. “To have a world leader in pharmaceutical manufacturing expand in our state rather than across the globe is proof that our investments in education, workforce development and infrastructure are paying off.”
GSK’s Zebulon facility has been in operation since 1983 and employs some 800 people.